Navigation Links
H1N1 Pandemic Flu Hits Pregnant Women Hard
Date:5/24/2010

Study underscores need for expectant moms to get flu shot, expert says

MONDAY, May 24 (HealthDay News) -- Pregnant women who get the H1N1 pandemic strain of flu are at high risk of experiencing serious complications for themselves and their unborn child, a new study finds.

According to the report, there has not been much data about the effect of the novel H1N1 flu on pregnant women and their fetuses, and what data exists is conflicting. In other pandemic flus -- in 1918 and 1957 -- pregnant women were at a high risk of being hospitalized and dying, the researchers noted.

"In keeping with prior pandemics, pregnant women don't do well with pandemic flu, because they have a compromised immune response," said influenza expert Dr. Marc Siegel, an associate professor of medicine at New York University in New York City.

In addition, they don't do as well because they lack immunity to these new flu strains. "So, if you put together that they don't have the immune response that you would like, plus they don't have previous immunity, it's a bad combination," he said.

The report is published in the May 24 issue of the Archives of Internal Medicine.

For the study, a team led by Dr. Andrew C. Miller, of the State University of New York Downstate Medical Center and Kings County Hospital Center in Brooklyn, looked at data on 18 pregnant women with H1N1 flu admitted to hospitals between May 18, 2009, and June 24, 2009.

These women were compared with pregnant women who had the 1918 and 1957 pandemic flu strains.

All the women in the current study were started on the antiviral drug oseltamivir (Tamiflu) when they were admitted to the hospital, the researchers noted.

Among these women, three were admitted to intensive care. In addition, seven women gave birth while they were in the hospital -- six prematurely.

Of the six premature births, five newborns had fetal distress syndrome, which involves a significant lowering of the fetal heart rate, and four were delivered by emergency Cesarean section. And while no congenital birth defects were seen, two infants died, according to the report.

"Little data are available regarding fetal outcomes and mortality rates among H1N1-infected mothers," the researchers wrote. "Of the 18 patients in this series, one had a spontaneous abortion and one died postnatally from complications of extreme prematurity and sepsis," they say. "H1N1 poses a serious health threat to pregnant patients."

This group of women responded to the new H1N1 in the same way pregnant women responded to other pandemic flus, Siegel said. "There is a high rate of complications, there is a high rate of early-term delivery, there is a high rate of deaths in fetuses This is all predictable," he said.

"This illustrates the importance of flu vaccine in pregnancy," Siegel added.

Going forward, Siegel does not expect to see a massive recurrence of the H1N1 flu. In this season's flu vaccine, the H1N1 pandemic strain will be one of the components of the shot, he noted.

More information

For more information on H1N1 flu, visit the Flu.gov.



SOURCES: Marc Siegel, M.D., associate professor, medicine, New York University, New York City; May 24, 2010, Archives of Internal Medicine


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Good Hygiene Does Slow Spread of Pandemic Flu
2. Fear of pandemic influenza clogs EDs even when disease is not present
3. Hand-washing, mask-wearing may limit transmission of pandemic flu
4. Personalizing medicine to prevent pandemics
5. Pandemic flu, like seasonal H1N1, shows signs of resisting Tamiflu
6. America's Hidden Pandemic: 100 Million Suffer From Sleep Problems
7. Most pandemic plans in Ontario hospitals have not been tested: Queens University study
8. Of swine, birds and men -- pandemic H1N1 flu
9. Genomic surveillance of pandemic H1N1
10. No Role Found for Birds in Swine Flu Pandemic
11. Canadian Health Organization Deploys IceWEB GIS To Track H1N1 Flu Pandemic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... Falls Church, VA (PRWEB) , ... ... ... to Integrate FDA Device Approval and Reimbursement , **An FDAnews Webinar**, Feb. ... , What are the critical reimbursement questions manufacturers should be asking ...
(Date:2/17/2017)... Seattle, WA (PRWEB) , ... February 17, 2017 ... ... health management organizations, has been named a finalist in the 8th Annual DecisionHealth ... impacting America's healthcare delivery system. Qualis Health’s work is recognized across multiple award ...
(Date:2/17/2017)... Tx (PRWEB) , ... February 17, 2017 , ... ... revenue cycle management services, announced today that Karen Pilley has been promoted to ... is critical in today’s shifting healthcare paradigm – a shift that demands the ...
(Date:2/17/2017)... ... February 17, 2017 , ... Cancer ... Molecular Medicine Tri-Conference February 20 – 22 in San Francisco. As part of ... anatomic and molecular pathology workflow solution, as well as its new precision medicine ...
(Date:2/17/2017)... ... February 17, 2017 , ... The Mason Pasquin Agency, ... and business owners in and around the Hampton Roads metropolitan region, is joining ... forms of domestic violence. , There are multiple categories of domestic violence – ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... 17, 2017 Research and Markets has announced the ... report to their offering. ... The report provides separate comprehensive analytics for the US, Canada ... Asia-Pacific , and Rest of World. Annual estimates and ... historic analysis is provided for these markets. Market data and analytics are ...
(Date:2/17/2017)... ST. LOUIS , Feb. 17, 2017   ... hospitals, has announced a new partnership with Engage ... the United States . FormFast will serve ... part of Engage,s implementations with MEDITECH .  ... that provides essential functionality to complement and enhance the ...
(Date:2/17/2017)... NEW YORK , Feb. 17, 2017  Noble ... coverage on ESSA Pharma Inc. (Nasdaq: EPIX ... Biotechnology Research, Kumar Raja , PhD. ... treatments for castration resistant prostate cancer (CRPC). Its lead ... selectively blocks the amino-terminal domain of the androgen receptor, ...
Breaking Medicine Technology: